After nearly two years of debate about its possible benefits and risks, the gene editing technique is now here to stay. An article in the December 27, 2015 edition of the Sunday Observer told of the first recorded use of the inexpensive CASPR-Cas9 gene editing technology to cut and ‘splice out’ bad genes and replace them with healthy genes.